IndraLab

Statements


| 1

reach
"We have already demonstrated that specific PDE4 inhibitors, Rolipram and Roflumilast, when preadministered systemically, upregulated CYLD and suppressed subsequent inflammation in the mouse models of middle ear inflammation (OM) and lung inflammation (XREF_FIG and XREF_FIG)."